Health · 6 views
Search for Alzheimer's drug unexpectedly finds possible biomarker
Researchers developed a drug for Alzheimer's disease and then discovered that the molecule already exists in human blood and is found at lower levels in cognitively impaired people.
AI Summary
Researchers designed a peptide that blocks amyloid‑β plaque growth, a strategy aimed at preventing or treating early Alzheimer’s disease. During development, they found the same peptide naturally occurs in human blood. Levels of the peptide are lower in people with cognitive impairment. The team is now investigating the molecule as both a potential biomarker and a therapeutic agent.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Baby who died from meningitis may have been saved if tested sooner, inquest findsContinue reading
- Social transition for trans young people an evolving processContinue reading
- Childhood environment may shape long-term mental health risk in children of parents with bipolar disorderContinue reading
- Long-Term MINT Data Support Durable Response to Inebilizumab in Myasthenia GravisContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow